NCT02551744View on ClinicalTrials.gov

Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers

NACompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Peptic Ulcer

Interventions

DRUG

histamine-2 receptor antagonist group

famotidine tab 40 mg qd for 6 months.

DRUG

proton pump inhibitor group

pantoprazole tab 40 mg qd for 6 months.

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors

lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02551744 - Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers | Biotech Hunter | Biotech Hunter